![]() |
市場調查報告書
商品編碼
2005686
全球整形外科植入契約製造市場報告:歷史資料及2021年至2032年預測Global Orthopedic Implant Contract Manufacturing Market Report, History and Forecast 2021-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
本報告中,全球整形外科植入契約製造市場指的是為整形外科OEM製造商外包植入肌肉骨骼醫療設備的工業化和生產。這包括機械加工、鍛造、鑄造、積層製造、塗層、精加工及相關製造支持,但不包括單一器械、托盤和包裝盒、電動工具、機器人硬體以及其他非植入整形外科產品。這一範圍與本報告中「僅限植入」的市場定義以及主要整形外科外包供應商就其整合製造能力所作的公開聲明相一致。
根據本報告提出的市場模型,全球整形外科植入契約製造市場預計將從2021年的46.0303億美元成長到2025年的77.0667億美元,到2032年達到186.5448億美元,2021年至2025年的年複合成長率為186.5448億美元,2021年至2025年的年複合成長率為13.8323232123年。因此,隨著外包在整個整形外科植入專案中滲透率的不斷提高以及製造流程日益複雜,該市場預計將保持強勁的中期成長動力。
依地區分類,北美仍然是最大的市場,市場規模將從2025年的43.6074億美元成長到2032年的96.1369億美元,而歐洲則保持其第二大區域市場的地位。亞太地區是主要區域中成長最快的,市場規模將從2025年的7.442億美元成長到2032年的28.738億美元,同期其銷售佔有率也將從9.66%成長到15.41%。這表明,儘管北美和歐洲仍然是市場的主要支撐,但未來的成長將越來越依賴亞洲主導。
依製造方法分類,「棒材和板材加工」將在2025年成為最大的細分市場,規模達26.097億美元,這反映了其在眾多整形外科植入類別中的廣泛應用。然而,最重要的結構性成長促進因素將是「積層製造+後處理」,其規模將從2025年的14.741億美元成長到2032年的55.9535億美元,市場佔有率也將從19.13%成長到29.99%。到2032年,積層製造的銷售額將略微超過棒材和板材加工,這表明植入製造流程正明顯朝著更複雜、高附加價值且對形狀設計要求更高的方向發展。
依應用領域分類,大型關節仍是最大的終端市場,預計將從2025年的28.1748億美元成長到2032年的63.1858億美元。脊椎是第二大細分市場,也是最具吸引力的成長領域之一,預計將從22.2435億美元成長到57.8128億美元,市場佔有率也將從28.86%上升到30.99%。肢體、小關節和運動醫學植入雖然基數較小,但其成長速度也超過了許多成熟領域,這表明外包需求超越傳統的重組專案。
競爭依然激烈,市場高度分散。截至2025年,主要企業包括Orchid Orthopedic Solutions、Marle、Cretex、Tecomet和AMETEK(Paragon Medical),但這五家公司合計僅佔全球銷售額的14.19%,其餘供應商佔據了79.89%的市場佔有率。總體而言,本報告指出,整形外科植入契約製造市場在2032年之前前景樂觀,成長動力主要來自OEM廠商持續的外包、對專業製程的需求以及積層製造、表面處理和其他技術先進的植入製造領域不斷提升的附加價值。
本報告目的是全面概述全球整形外科植入契約製造市場,並結合定量和定性分析。其目標是幫助讀者制定業務/成長策略、評估市場競爭、分析自身當前市場地位,並就整形外科植入植入契約製造做出明智的商業決策。
為了更深入了解市場,本報告提供了競爭格局、主要競爭對手及其市場排名的概況,並探討了技術趨勢和新產品開發。
本報告目的是幫助讀者了解產業競爭格局,以及如何在競爭激烈的環境中拓展潛在利潤。報告重點分析全球整形外科植入契約製造市場的競爭格局,詳細介紹主要企業的市場佔有率、行業排名、競爭對手生態系統、市場表現、新產品開發、業務狀況、擴張和收購活動。這有助於讀者識別主要競爭對手,並深入了解市場競爭模式。
市場區隔
本報告依公司、類型、應用、地區和國家/地區對整形外科植入契約製造市場進行了分析,提供了歷史時期和預測期(2021-2026年、2027-2032年,以2024年為基準年)的市場規模和年複合成長率(CAGR)。報告也指出了各細分市場的潛在商機,並說明了該市場極具吸引力的投資提案矩陣。
依公司
依類型細分
依用途細分
依地區
The global orthopedic implant contract manufacturing market in this report is defined as the outsourced industrialization and production of implantable musculoskeletal devices for orthopedic OEMs, including machining, forging, casting, additive manufacturing, coating, finishing, and related manufacturing support, while excluding standalone instruments, trays and cases, powered tools, robotics hardware, and other non-implant orthopedic products. This scope is consistent with both the report's implant-only market definition and the way major orthopedic outsourcing suppliers publicly describe their integrated manufacturing capabilities.
Based on the report's market model, the global orthopedic implant contract manufacturing market increased from US$4,603.03 million in 2021 to US$7,706.67 million in 2025, and is forecast to reach US$18,654.48 million by 2032, representing a 13.8% CAGR in 2021-2025 and 13.4% CAGR in 2026-2032. The market therefore remains on a strong medium-term growth trajectory, supported by expanding outsourcing penetration and rising manufacturing complexity across orthopedic implant programs.
From a regional perspective, North America remains the largest market, rising from US$4,360.74 million in 2025 to US$9,613.69 million by 2032, while Europe remains the second-largest regional market. Asia-Pacific is the fastest-growing major region, expanding from US$744.20 million in 2025 to US$2,873.80 million in 2032, with its revenue share increasing from 9.66% to 15.41% over the same period. This indicates that while the market remains anchored in North America and Europe, future incremental growth is becoming increasingly Asia-led.
By manufacturing route, Bar & Plate Machining is the largest segment in 2025 at US$2,609.70 million, reflecting its broad applicability across orthopedic implant categories. However, Additive Manufacturing + Post-processing is the most important structural growth engine, rising from US$1,474.10 million in 2025 to US$5,595.35 million in 2032, with segment share increasing from 19.13% to 29.99%. By 2032, additive manufacturing slightly surpasses Bar & Plate Machining in revenue share, indicating a clear shift toward more complex, higher-value, geometry-intensive implant manufacturing workflows.
By application, Large Joints remain the largest end market, growing from US$2,817.48 million in 2025 to US$6,318.58 million in 2032. Spine is the second-largest segment and one of the most attractive growth areas, increasing from US$2,224.35 million to US$5,781.28 million, while its share rises from 28.86% to 30.99%. Extremities & Small Joints and Sports Medicine Implantables also grow faster than many mature categories from smaller bases, indicating that outsourcing demand is broadening beyond traditional reconstruction programs.
Competitive intensity remains high and the market is notably fragmented. In 2025, the leading companies include Orchid Orthopedic Solutions, Marle, Cretex, Tecomet, and AMETEK (Paragon Medical), but the top five together account for only 14.19% of global revenue, while the long tail of other suppliers represents 79.89% of the market. Overall, the report suggests that the orthopedic implant contract manufacturing market offers a favorable outlook through 2032, with growth driven by continued OEM outsourcing, demand for specialist processes, and increasing value capture in additive, surface-engineering, and other technically demanding implant manufacturing segments.
This report aims to provide a comprehensive presentation of the global market for Orthopedic Implant Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orthopedic Implant Contract Manufacturing.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orthopedic Implant Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Orthopedic Implant Contract Manufacturing segments by company, by Type, by Application, by region and country, and provides market size and CAGR for the history and forecast period (2021-2026, 2027-2032), considering 2024 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2026, 2027-2032). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Orthopedic Implant Contract Manufacturing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion